Peter Vandenberghe

14PUBLICATIONS
77CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunityRespiratory diseasesCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 06, 2026
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMT.

|Oct 31, 2025
Treatment of chronic myeloid leukemia chronic phase patients in third-line setting and beyond: recommendations from a Belgian expert panel in 2025.

Peter Vandenberghe, Dominiek Mazure, Gaëlle Vertenoeil

|Oct 17, 2024
Single center, real-world retrospective study of CAR-T cell therapy for relapsed/refractory large B-cell lymphoma beyond second line: five-year results at the University Hospitals Leuven.

Jan Brijs, Jonas Van Ham, Benedicte Dubois

|Sep 18, 2024
Single center, real-world retrospective study of CAR-T cell therapy for relapsed/refractory large B-cell lymphoma beyond second line: five-year results at the University Hospitals Leuven.

Jan Brijs, Jonas Van Ham, Benedicte Dubois

|Dec 11, 2023
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.

Stefan K Alig, Mohammad Shahrokh Esfahani, Andrea Garofalo

|May 02, 2023
Revisiting a case of idiopathic hypereosinophilic syndrome with novel molecular techniques identifies a second case of a myeloid/lymphoid neoplasm with a SART3::PDGFRB fusion.

Quentin Van Thillo, Barbara Dewaele, Jolien De Bie

Pageof 3

Frequent Collaborators

2 joint publications

Kim De Keersmaecker

2 joint publications

Daan Dierickx

2 joint publications

Jan Cools

2 joint publications

Vibeke Vergote